Amneal Pharmaceuticals Gains FDA Approval for Lanreotide Injection, Adding a Third Competitor to a High-Value Specialty Market
"Despite multiple generic approvals, the market for lanreotide injections has demonstrated resilience, with brand sales growing rather than shrinking, raising questions about whether patients will see immediate cost savings with…